All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

3 things to remember when diagnosing patients with MGUS

During the 7th World Congress on Controversies in Multiple Myeloma (COMy), the Multiple Myeloma Hub spoke with Graham Jackson, Newcastle University, Newcastle upon Tyne, UK. He discusses three things to remember when diagnosing patients with monoclonal gammopathy of uncertain significance (MGUS).

3 things to remember when diagnosing patients with MGUS

When considering diagnosis for MGUS, Jackson outlines the importance of detecting oligosecretory or non-secretory multiple myeloma, assessing risk of progression, and clinical problems associated with certain cases.
  
Share: